• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine].

作者信息

Heier H E

机构信息

Blodbank og immunologisk avdeling, Ullevål sykehus, Oslo.

出版信息

Tidsskr Nor Laegeforen. 1993 Jan 10;113(1):18-22.

PMID:8424244
Abstract

In Norway self-sufficiency has been achieved with regard to all major blood products, despite a relatively low number of blood donations. There is good balance in the consumption of the various products. The total consumption of erythrocytes has gone down only slightly since pre-HIV times, while consumption of thrombocytes has increased. There is probably an over consumption of erythrocytes, albumin and plasma, and more attention should be given to the consistent application of principles of modern haemotherapy. If each department is given responsibility for its own economy, improvement may be achieved in this respect.

摘要

相似文献

1
[Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine].
Tidsskr Nor Laegeforen. 1993 Jan 10;113(1):18-22.
2
[Changes in consumption of blood--the significance of resource related and economic factors].血液消耗的变化——资源相关因素和经济因素的重要性
Tidsskr Nor Laegeforen. 1993 Jan 10;113(1):61-5.
3
[Transfusion medicine in unified Europe].[统一欧洲的输血医学]
Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:12-5.
4
Optimizing blood component preparation: qualitative, logistic and economic aspects.优化血液成分制备:质量、物流和经济方面。
Biomed Biochim Acta. 1990;49(2-3):S198-203.
5
[Quality assurance management system for therapy with blood and blood products].[血液及血液制品治疗的质量保证管理体系]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Oct;33(10):664-5. doi: 10.1055/s-2007-994830.
6
Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.血液问题自我评估及管理的实践层面:两家医院经验回顾
Am J Clin Pathol. 1997 Apr;107(4 Suppl 1):S17-22.
7
[Transfusion medicine in unified Europe. Brief report on the status of transfusion medicine in central and east European countries].[统一欧洲的输血医学。中东欧国家输血医学现状简要报告]
Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:16-8.
8
[Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].[德国医学协会血液成分与血浆衍生物治疗指南——引言。血液疗法中基于证据的风险效益分析建议]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Mar;44(3):186-97; quiz 199. doi: 10.1055/s-0029-1215550. Epub 2009 Mar 5.
9
[Costs of safety of blood and blood products].
Zentralbl Chir. 1995;120(8):584-92.
10
[Risk management from the perspective of the hematologist].血液科医生视角下的风险管理
Z Arztl Fortbild Qualitatssich. 2003 Nov;97(8-9):618-21.